Literature DB >> 11174374

Identification of a PTEN mutation in a family with Cowden syndrome and Bannayan-Zonana syndrome.

M Wanner1, J T Celebi, M Peacocke.   

Abstract

Cowden syndrome (CS) and Bannayan-Zonana syndrome (BZS) are two inherited hamartoma syndromes characterized by distinct phenotypic features. Mutations in the PTEN gene have been identified in patients with CS and BZS, suggesting the presence of a common genetic basis. We describe a single kindred with individuals manifesting both CS and BZS phenotypes (CS/BZS overlap family) in which we have identified a novel mutation in PTEN by DNA sequencing. We have confirmed these results by means of restriction enzyme analysis. The presence of individuals with CS and BZS within the same family, and moreover the identification of identical PTEN gene mutations in these individuals, suggest that these two syndromes represent different phenotypic expressions of one disease. Furthermore, these findings imply that, like patients with CS, individuals with BZS should be monitored for the onset of malignancy.

Entities:  

Mesh:

Year:  2001        PMID: 11174374     DOI: 10.1067/mjd.2001.110390

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  8 in total

1.  FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis.

Authors:  Ji-Hye Paik; Ramya Kollipara; Gerald Chu; Hongkai Ji; Yonghong Xiao; Zhihu Ding; Lili Miao; Zuzana Tothova; James W Horner; Daniel R Carrasco; Shan Jiang; D Gary Gilliland; Lynda Chin; Wing H Wong; Diego H Castrillon; Ronald A DePinho
Journal:  Cell       Date:  2007-01-26       Impact factor: 41.582

2.  Differential requirements for c-Myc in chronic hematopoietic hyperplasia and acute hematopoietic malignancies in Pten-null mice.

Authors:  J Zhang; Y Xiao; Y Guo; P Breslin; S Zhang; W Wei; Z Zhang; J Zhang
Journal:  Leukemia       Date:  2011-09-16       Impact factor: 11.528

3.  Bannayan-Riley-Ruvalcaba syndrome: MRI neuroimaging features in a series of 7 patients.

Authors:  R Bhargava; K J Au Yong; N Leonard
Journal:  AJNR Am J Neuroradiol       Date:  2013-08-01       Impact factor: 3.825

Review 4.  Protean PTEN: form and function.

Authors:  Kristin A Waite; Charis Eng
Journal:  Am J Hum Genet       Date:  2002-03-01       Impact factor: 11.025

5.  Bannayan-Riley-Ruvalcaba syndrome: further delineation of the phenotype and management of PTEN mutation-positive cases.

Authors:  Y M C Hendriks; J T C M Verhallen; J J van der Smagt; S G Kant; Y Hilhorst; L Hoefsloot; K B-M Hansson; P J C van der Straaten; H Boutkan; M H Breuning; H F A Vasen; A H J T Bröcker-Vriends
Journal:  Fam Cancer       Date:  2003       Impact factor: 2.375

6.  Muscle hemangiomatosis presenting as a severe feature in a patient with the pten mutation: expanding the phenotype of vascular malformations in bannayan-riley-ruvalcaba syndrome.

Authors:  Y Soysal; T Acun; Cm Lourenço; W Marques; Mc Yakıcıer
Journal:  Balkan J Med Genet       Date:  2012-06       Impact factor: 0.519

Review 7.  Phosphoinositide phosphatases in a network of signalling reactions.

Authors:  Daniel Blero; Bernard Payrastre; Stéphane Schurmans; Christophe Erneux
Journal:  Pflugers Arch       Date:  2007-06-29       Impact factor: 4.458

8.  Familial multiple lipomas coexisting with celiac disease: a case report.

Authors:  Ilyas Sayar; Levent Demirtas; Mehmet Gurbuzel; Arda Isik; Kemal Peker; Baris Gulhan
Journal:  J Med Case Rep       Date:  2014-09-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.